4//SEC Filing
Talecris Biotherapeutics Holdings Corp. 4
Accession 0001225208-10-020446
CIK 0001405197operating
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:16 PM ET
Size
11.0 KB
Accession
0001225208-10-020446
Insider Transaction Report
Form 4
LYNCH THOMAS J
Sr. VP, Corp. Compliance
Transactions
- Exercise/Conversion
Options (right to buy)
2010-09-03$1.39/sh−105,440$146,562→ 0 totalExercise: $1.39From: 2006-04-01Exp: 2015-11-10→ Common Stock (105,440 underlying) - Exercise/Conversion
Common Stock
2010-09-03$1.39/sh+105,440$146,562→ 126,560 total - Exercise/Conversion
Common Stock
2010-09-03$11.00/sh+8,000$88,000→ 134,560 total - Exercise/Conversion
Options (right to buy)
2010-09-03$11.00/sh−8,000$88,000→ 0 totalExercise: $11.00From: 2008-04-01Exp: 2017-07-09→ Common Stock (8,000 underlying)
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit
- [F3]The option is fully vested and immediately exercisable.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001405197
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 4:16 PM ET
- Size
- 11.0 KB